Impel NeuroPharma Inc. (IMPL) Launches 3M Share Proposed Offering

Impel NeuroPharma, Inc. (NASDAQ: IMPL) announced that it has commenced an underwritten public offering of 3,000,000 shares of its common stock. All of the shares of common stock are being offered by Impel. In addition, Impel intends to grant the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock at the offering price, less underwriting discounts and commissions.

Cowen and Guggenheim Securities are acting as joint bookrunning managers for the proposed offering. Wedbush PacGrow is acting as lead manager.

You May Also Be Interested In

• SOPHiA Genetics closes $57.5M public offering at $4.75 per share
• Oracle expands equity distribution agreement with 15 additional sales agents
• MoonLake proposes $150M public offering of Class A shares